INS and Obesity: An emerging hypothesis is that metabolic aberrations accompanied with obesity lead to changes in hormones and cytokines, including insulin, and serum insulin may play a role in BE progression through a number of mechanisms.[4,14] In a word, each of these mechanisms proves a metabolic abnormality in DM patients and could underlie the association between EC and DM.